Citation Impact
Citing Papers
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
2011
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study
2016
Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories
2010
Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
2014
Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis
2018 StandoutNobel
HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity
2013
Borderline HER‐2 breast cancer cases: Histochemical versus real‐time PCR analysis and impact of different cut‐off values
2007
NMR-based metabolic profiling of human hepatoma cells in relation to cell growth by culture media analysis
2006
HER-2/neu Assessment in Breast Cancer Using the Original FDA and New ASCO/CAP Guideline Recommendations
2008
Target Binding Properties and Cellular Activity of Afatinib (BIBW 2992), an Irreversible ErbB Family Blocker
2012 Standout
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer
2010
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
2018 Standout
PGDS, A Novel Technique Combining Chromogenic In Situ Hybridization and Immunohistochemistry for the Assessment of ErbB2 (HER2/neu) Status in Breast Cancer
2007
Innate Lymphoid Cells in Inflammation and Immunity
2014
A view on drug resistance in cancer
2019 StandoutNature
From tumour heterogeneity to advances in precision treatment of colorectal cancer
2016
Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations
2008
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
2016
Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production
2008 Standout
Systemic manifestations and comorbidities of COPD
2009
Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor
2013
IL-25-responsive, lineage-negative KLRG1hi cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells
2014
Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics
2010 StandoutNobel
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
2013
Cancer drug resistance: an evolving paradigm
2013 Standout
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
2010
Application of second-generation sequencing to cancer genomics
2010
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Cancer stem cells revisited
2017 Standout
Colorectal cancer
2013 Standout
Selective Diaphragmatic Mitochondrial Abnormalities in a Patient with Marked Air Flow Obstruction
1996
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
2012 Nature
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Colorectal cancer
2019 Standout
The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy
2005
Antibody therapy of cancer
2012 Standout
Lipodystrophy in HIV 1-infected patients: lessons for obesity research
2007
C-MET as a new therapeutic target for the development of novel anticancer drugs
2010
Complex chronic comorbidities of COPD
2007
The essence of senescence: Figure 1.
2010 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Current understanding of the human microbiome
2018 Standout
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
2015
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
The causes and consequences of genetic heterogeneity in cancer evolution
2013 StandoutNature
Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action
2013
Oxidative stress of myosin contributes to skeletal muscle dysfunction in rats with chronic heart failure
2006
Unique features of long non-coding RNA biogenesis and function
2015 Standout
Autophagy and Aging
2011 Standout
Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA
2020
The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
2010
miR-19 is a key oncogenic component of mir-17-92
2009
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event
2009
Metastatic colonization by circulating tumour cells
2016 StandoutNature
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior
2011
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
2009 Standout
The biology of innate lymphoid cells
2015 Nature
Control of adaptive immunity by the innate immune system
2015 Standout
Neutrophil ageing is regulated by the microbiome
2015 Nature
Cellular senescence: from physiology to pathology
2014 Standout
Biomarker-driven and molecular targeted therapies for colorectal cancers
2017
Molecular pathogenesis of mantle cell lymphoma
2012
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Protein Carbonylation in Skeletal Muscles: Impact on Function
2009
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
2017 Standout
Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing
2008
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment
2016
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
2015
Activated group 3 innate lymphoid cells promote T-cell–mediated immune responses
2014
Ultraviolet B–Induced Maturation of CD11b-Type Langerin− Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin
2017 StandoutNobel
Transcriptome sequencing in Sézary syndrome identifies Sézary cell and mycosis fungoides-associated lncRNAs and novel transcripts
2012
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Redox Proteomics: Chemical Principles, Methodological Approaches and Biological/Biomedical Promises
2012
Four faces of cellular senescence
2011 Standout
Biomarkers of Oxidative Damage in Human Disease
2006
Innate lymphoid cells: A new paradigm in immunology
2015 Science
A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data
2011 Standout
Cancer Genome Landscapes
2013 StandoutScience
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues
2006
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Evaluation of Her-2/neu Status in Carcinomas With Amplified Chromosome 17 Centromere Locus
2006
Performance of Chromogenic In Situ Hybridization on Testing HER2 Status in Breast Carcinomas With Chromosome 17 Polysomy and Equivocal (2+) HercepTest Results
2009
Creatine Kinase Gene Mutation in a Patient with Muscle Creatine Kinase Deficiency
2001 StandoutNobel
Creatine and Creatinine Metabolism
2000 Standout
Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18
2016
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Sergi Serrano being referenced
MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas
2009
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistry
2005
Absence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas
2011
Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells
2014
Hyperthyroid Myopathy with Mitochondrial Paracrystalline Rectangular Inclusions
1996
Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer
2012
Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy
2002
Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment
2006
KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations
2008
Clonal proliferation of cyclin D1–positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?
2005
FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors
2009
Oxidative Stress and Respiratory Muscle Dysfunction in Severe Chronic Obstructive Pulmonary Disease
2005
Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin
2009
Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization.
2004